These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9155516)

  • 121. Predictive properties of serum prostate-specific antigen testing in a community setting.
    Volk RJ; Spann SJ; Mold JW
    Arch Intern Med; 1997 Aug 11-25; 157(15):1765-6. PubMed ID: 9250239
    [No Abstract]   [Full Text] [Related]  

  • 122. Prostate cancer: screening approaches.
    Donovan JL; Martin RM; Neal DE; Hamdy FC
    Br J Hosp Med (Lond); 2005 Nov; 66(11):623-6. PubMed ID: 16308948
    [TBL] [Abstract][Full Text] [Related]  

  • 123. The case against.
    Donovan JL; Hamdy FC; Neal DE;
    Ann R Coll Surg Engl; 2005 Mar; 87(2):90-1. PubMed ID: 16790127
    [No Abstract]   [Full Text] [Related]  

  • 124. An update on prostate cancer.
    Klein EA
    Cleve Clin J Med; 1995; 62(5):325-38. PubMed ID: 7586489
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Prostate cancer: 4 big questions.
    Hodson R
    Nature; 2015 Dec; 528(7582):S137. PubMed ID: 26672789
    [No Abstract]   [Full Text] [Related]  

  • 126. Screening for prostate cancer in the UK. Seems to be creeping in by the back door.
    Donovan JL; Frankel SJ; Neal DE; Hamdy FC
    BMJ; 2001 Oct; 323(7316):763-4. PubMed ID: 11588064
    [No Abstract]   [Full Text] [Related]  

  • 127. Prostate cancer screening.
    Ablin AJ
    Lancet; 2001 Apr; 357(9263):1201-2; author reply 1201-2. PubMed ID: 11332425
    [No Abstract]   [Full Text] [Related]  

  • 128. Screening for prostate cancer.
    Beatty JD
    BJU Int; 2010 Jan; 105(1):131. PubMed ID: 20132106
    [No Abstract]   [Full Text] [Related]  

  • 129. Screening for prostate cancer: the way ahead.
    Kirby RS; Eeles RA; Kote-Jarai Z; Guy M; Easton D; Fitzpatrick JM
    BJU Int; 2010 Feb; 105(3):295-7. PubMed ID: 20089095
    [No Abstract]   [Full Text] [Related]  

  • 130. Prostate Cancer and Prostatic Diseases. Editor's comments.
    Freedland SJ
    Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):295. PubMed ID: 21068743
    [No Abstract]   [Full Text] [Related]  

  • 131. [Screening for early diagnosis of prostatic cancer].
    Møller P; Fosså SD; Heimdal K; Kvinnsland S; Giercksky KE; Woehre H
    Tidsskr Nor Laegeforen; 1994 Apr; 114(9):1104-5. PubMed ID: 8009529
    [No Abstract]   [Full Text] [Related]  

  • 132. Re: The clinical usefulness of prostate specific antigen: update 1994.
    Visvanathan K
    J Urol; 1996 Jan; 155(1):294; author reply 295. PubMed ID: 7490868
    [No Abstract]   [Full Text] [Related]  

  • 133. The role of biomarkers in the detection and treatment of prostate cancer.
    Ward-Smith P
    Urol Nurs; 2013; 33(4):161-2. PubMed ID: 24079112
    [No Abstract]   [Full Text] [Related]  

  • 134. Defining clinically significant prostate cancer: pathologic criteria versus outcomes data.
    Albertsen PC
    J Natl Cancer Inst; 1996 Sep; 88(17):1177-8. PubMed ID: 8780622
    [No Abstract]   [Full Text] [Related]  

  • 135. A prostate screening perspective.
    Walther PJ
    N C Med J; 1996; 57(6):341. PubMed ID: 8937155
    [No Abstract]   [Full Text] [Related]  

  • 136. Transrectal US of the prostate: is the technology leading the science?
    McClennan BL
    Radiology; 1988 Aug; 168(2):571-5. PubMed ID: 3293115
    [No Abstract]   [Full Text] [Related]  

  • 137. Professor was harassed by his university after criticising routine prostate cancer screening, inquiry finds.
    Lenzer J
    BMJ; 2012 Jun; 344():e4150. PubMed ID: 22700817
    [No Abstract]   [Full Text] [Related]  

  • 138. To screen or not to screen? The prostate cancer question.
    Dickman S
    Ann Oncol; 1996 Sep; 7(7):648-9. PubMed ID: 8905018
    [No Abstract]   [Full Text] [Related]  

  • 139. Model favours more personalised screening for prostate cancer.
    BMJ; 2013 Feb; 346():f711. PubMed ID: 23390254
    [No Abstract]   [Full Text] [Related]  

  • 140. Background for screening: natural history and treatment.
    Whitmore WF
    Prog Clin Biol Res; 1988; 269():123-30. PubMed ID: 3393549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.